Filing Details

Accession Number:
0001181431-13-047163
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-03 09:28:55
Reporting Period:
2013-08-29
Filing Date:
2013-09-03
Accepted Time:
2013-09-03 09:28:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1292519 Invivo Therapeutics Holdings Corp. NVIV Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1451495 F. Sean Moran C/O Invivo Therapeutics Holdings Corp.
One Kendall Square, Suite B14402
Cambridge MA 02139
Acting Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-29 28,000 $1.23 28,000 No 4 S Direct
Common Stock Acquisiton 2013-08-30 12,000 $1.47 40,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.18 to $1.24, inclusive. The reporting person undertakes to provide InVivo Therapeutics Holdings Corp. ("InVivo"), any security holder of InVivo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 through 2.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.49, inclusive.